ENTITY
CSL Ltd

CSL Ltd (CSL AU)

111
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
Refresh
20 Feb 2019 07:43

Aussie Reporting Season Update: February 2019

The Banks remain under earnings pressure from several fronts, with weak credit growth, falling net interest margins and rising compliance costs...

Logo
522 Views
Share
05 Dec 2018 06:37

Aussie Equities 2019: On a Wing and a Prayer

We expect 2019 will be challenging. Offshore macro and Geopolitical issues emerged in 2018 to dash our expectations of a good year for the Aussie...

Logo
473 Views
Share
18 Nov 2018 14:21

Low Tide on Aussie Growth Stocks

Growth isn’t Dead Yet. Value’s outperformance in the past couple of months is relatively small compared to past periods and we think the...

Logo
350 Views
Share
20 Oct 2018 08:35

It’s Not Over Yet, but Lift the Bar on Defence

A Correction and Not the End of the Cycle. In our view, the equity market sell-off in the past few weeks is a correction and a return to more...

Logo
412 Views
Share
30 Sep 2018 06:56

Aussie Equities Month in Review (Sept 2018)

Giving Back Reporting Season Gains. In our view, reporting season was relatively solid, with 8% EPS growth achieved in FY18 and another 8%...

Logo
349 Views
Share
x